ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,032.22
      -0.78%
      US Tech 100
      16,909.60
      -0.88%
      Dow Jones
      38,004.67
      -1.19%
      Brent Oil
      86.885
      -0.38%
      Bitcoin
      64,615.00
      0.52%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Annovis Bio Inc (ANVS)

      7. Annovis Bio Inc (ANVS) News

      ANVS

      Annovis Bio (ANVS)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ANVS
      DateTimeSourceHeadlineSymbolCompany
      12:52PMiHub NewswireFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      04/02/20247:30AMGlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial ResultsNYSE:ANVSAnnovis Bio Inc
      02/28/20247:08AMIH Market NewsUS Stock Movers Before Market: Beyond Meat, eBay, First Solar, Urban Outfitters…NYSE:ANVSAnnovis Bio Inc
      02/12/20242:00PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NYSE:ANVSAnnovis Bio Inc
      02/01/20244:05PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:ANVSAnnovis Bio Inc
      11/22/20234:27PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
      11/22/20234:24PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
      11/22/20234:21PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
      11/22/20234:14PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
      11/21/20232:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
      11/21/20232:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
      11/21/20232:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
      11/21/20232:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
      11/08/20234:45PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
      11/02/20237:30AMBusiness WireAnnovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s PatientsNYSE:ANVSAnnovis Bio Inc
      11/01/202312:28PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
      11/01/202312:24PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ANVSAnnovis Bio Inc
      10/31/20238:00AMBusiness WireAnnovis Bio Announces Pricing of $7.5 Million Public OfferingNYSE:ANVSAnnovis Bio Inc
      10/30/20235:27PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ANVSAnnovis Bio Inc
      10/30/20235:17PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
      10/30/20234:48PMBusiness WireAnnovis Bio Announces Launch of Proposed Public OfferingNYSE:ANVSAnnovis Bio Inc
      10/30/20234:42PMBusiness WireAnnovis Bio Receives Positive Recommendation to Continue Phase 2/3 Trial of Buntanetap for Alzheimer’s Disease Patients From the Independent Data and Safety Monitoring Board (DSMB)NYSE:ANVSAnnovis Bio Inc
      10/24/20239:13AMBusiness WireAnnovis Bio Showcases Promising Progress in Novel Drug Development at the 2023 Clinical Trials on Alzheimer's Disease ConferenceNYSE:ANVSAnnovis Bio Inc
      09/21/20239:35AMGlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNYSE:ANVSAnnovis Bio Inc
      08/15/20237:20AMBusiness WireAnnovis Bio Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateNYSE:ANVSAnnovis Bio Inc
      08/14/20234:40PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
      07/18/20238:18AMBusiness WireContinued Positive Performance of Novel Drug Development by Annovis Bio Presented at 2023 Alzheimer's Association International ConferenceNYSE:ANVSAnnovis Bio Inc
      06/27/20237:30AMBusiness WireAnnovis Bio Announces the Filing of a Groundbreaking PatentNYSE:ANVSAnnovis Bio Inc
      06/20/202312:05PMBusiness WireAnnovis Bio Receives Excellent Safety Rating and Positive Recommendation to Continue Phase III Trial of Buntanetap for Parkinson’s Disease Patients from the Independent Data and Safety Monitoring Board (DSMB)NYSE:ANVSAnnovis Bio Inc
      06/16/20234:19PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ANVSAnnovis Bio Inc
       Showing the most relevant articles for your search:NYSE:ANVS